PubMed Health⌕ Search

Biomedical subjects

Licesio J Rodríguez

Publications and source records attributed to Licesio J Rodríguez.

2 recordsLinked to original sources

Ternary naproxen: beta-cyclodextrin:polyethylene glycol complex formation.

The aim of this study was to investigate the effect of the presence of the water-soluble polymer polyethylene glycol (PEG)-MW=35000 g/mol-on the complexation of the phototoxic anti-inflammatory drug naproxen, in its sodium salt form, with beta-cyclodextrin (beta-CD). The data revealed that the polymer does not interact with the uncomplexed naproxen whereas it does with the beta-CD. The presence of different proportions of PEG, in the 0-1% (w/w) range, systematically lowers K(app) of the formation of the naproxen:beta-CD inclusion complex. The reason for the decrease in the complexed drug is the presence of other competing equilibria, the first one is an interaction of the polymer with the beta-CD, which in turn reduces the amount of free CD available for including the naproxen, and the second is the formation of a naproxen:beta-CD:PEG ternary complex with lower affinity than the binary complex. The binding constant of these processes are K(2)=(4.5+/-1.0) x 10(5) M(-1) and K(3)=870+/-19 M(-1), respectively. In addition the presence of the PEG produces an important change in the driving force of the complex formation. In this case the process is enthalpically unfavoured and entropically favoured; these are typical characteristics of processes governed by hydrophobic interactions.

Cyclodextrins↗

Effect of PVP K-25 on the formation of the naproxen:beta-ciclodextrin complex.

The aim of this study was to investigate the effects of the presence of the water-soluble polymer polyvinylpyrrolidone K-25 (MW=24000g/mol) on the complexation of the AINE naproxen, in its sodium salt form, with the beta-cyclodextrin. The data revealed that the polyvinylpyrrolidone K-25 interacts with the drug as well as with the drug:beta-cyclodextrin inclusion complex. The polymer shows more affinity for the inclusion complex, K=(6.67+/-0.292) x 10(-5)M(-1) than for the free drug, (2.08+/-0.208) x 10(-5)M(-1). The presence of different proportions of polymer, in a range 0-1% (w/w) of polyvinylpyrrolidone, does not increase the ability of drug-cyclodextrin complexation but important changes in the driving force of complex formation were detected, depending on the percentage of polyvinylpyrrolidone K-25 present. At low polymer concentrations, the complexation process is driven entropically, while at higher PVP proportions it is enthalpically favored. In the ternary system, polyvinylpyrrolidone K-25 partially or totally coats the drug:beta-cyclodextrin inclusion complex interacting with the beta-cyclodextrin (through hydrogen bonds), and with the naproxen.

Anti-Inflammatory Agents, Non-Steroidal↗